Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  St Jude Medical Inc    STJ

News SummaryMost relevantAll newsSector newsTweets

St. Jude Medical, Inc. : St Jude To Stop Selling Another Version Of Defibrillator Wires

share with twitter share with LinkedIn share with facebook
share via e-mail
04/04/2012 | 03:48pm CEST

St. Jude Medical Inc. (STJ) will stop selling another version of its defibrillator wires in an effort to head off potential problems like those the medical-device maker is currently battling with its Riata and Riata ST wires.

The Riata defibrillator wires, called leads, are no longer on the market but are still implanted in thousands of patients in the U.S. In a medical journal last month, prominent cardiologist Robert G. Hauser wrote that the cables are responsible for at least 20 deaths.

Wednesday, the company said it will cease selling its QuickSite and QuickFlex left-ventricular leads used to connect cardiac resynchronization therapy devices to the heart. Roughly 171,000 QuickSite and QuickFlex leads have been sold worldwide.

The decision comes as St. Jude has confirmed 39 cases of the metal wires wearing through their silicone covering, leading to an incidence rate of 2.3 in every 10,000 leads. Still, it stressed that its decision to stop selling the wires is a proactive one.

"It is important to note, however, that the overall safety and reliability of QuickSite and QuickFlex leads continues to be comparable to currently available CRT leads from other manufacturers," the company wrote.

The wire leads connect life-saving medical devices, which are placed under the skin in the shoulder area, to the heart and delivers a jolt that restores proper rhythm. Because of the constant pounding motion of the heart, the thin leads can be damaged.

Shares closed Tuesday at $43.80 and were inactive in premarket trading. The stock is up roughly 36% from lows hit late last year when the Food and Drug Administration termed the Riata defibrillator issues as a Class I recall, which applies to grave dangers like chance of death.

   -By Mia Lamar, Dow Jones Newswires; 212-416-3207; [email protected] 

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ST JUDE MEDICAL INC
06/01 ST JUDE MEDICAL : Patent Issued for Surgical Heart Valve Flexible Stent Frame St..
06/01 ST JUDE MEDICAL : "Leaflet-Cuff Attachments for Prosthetic Heart Valve" in Paten..
05/25 ST JUDE MEDICAL : Patent Issued for Catheter with Atraumatic Tip (USPTO 9649155)
05/25 ST JUDE MEDICAL : An Application for the Trademark "COOL PATH" Has Been Filed by..
05/18 ST JUDE MEDICAL : Patent Issued for System for Loading a Collapsible Heart Valve..
05/18 ST JUDE MEDICAL : Studies from St. Jude Medical, Inc. in the Area of Cardiology ..
05/18 ST JUDE MEDICAL : Patent Issued for Apparatus and Method for Heart Valve Repair ..
05/18 ST JUDE MEDICAL : Patent Issued for Medical Catheter with Deflection Pull Ring a..
05/11 ST JUDE MEDICAL : "Alignment of an Implantable Medical Device" in Patent Applica..
05/11 ST JUDE MEDICAL : Class-action lawsuit initiated over potentially defective card..
More news
News from SeekingAlpha
04/27 DIVIDEND STREAKS IN DANGER : 2016 Review And 2017 Preview
04/18 Abbott-Alere Deal To Go Ahead
02/17 GLAZER CAPITAL : Merger Arbitrage With Convertibles - A Lower Risk Alternative
02/15 Panel To Stand Sentinel Over Embolic Filter
02/01 Dividend Champions For February 2017
Michael T. Rousseau President, Chief Executive Officer & Director
Scott P. Thome Vice President-Global Operations & Supply Chain
Mark D. Carlson Chief Medical Officer & VP-Global Clinical Affairs
Mark W. Murphy Chief Information Officer & Vice President-IT
Philip J. Ebeling Chief Technology Officer & Vice President
Sector and Competitors
1st jan.Capitalization (M$)
SMITH & NEPHEW16.46%16 497
JAPAN LIFELINE CO., LTD.140.99%2 336
GLAUKOS CORP-2.83%1 148